Monogram Orthopaedics Past Earnings Performance
Past criteria checks 0/6
Monogram Orthopaedics's earnings have been declining at an average annual rate of -31.9%, while the Medical Equipment industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 23.3% per year.
Key information
-31.9%
Earnings growth rate
-10.0%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 23.3% |
Return on equity | -131.0% |
Net Margin | -3,669.7% |
Next Earnings Update | 22 May 2024 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How Monogram Orthopaedics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 0 | -13 | 6 | 11 |
31 Dec 23 | 0 | -14 | 7 | 11 |
30 Sep 23 | 0 | -13 | 8 | 9 |
30 Jun 23 | 0 | -16 | 7 | 7 |
31 Mar 23 | 0 | -13 | 5 | 6 |
31 Dec 22 | 0 | -14 | 5 | 5 |
30 Sep 22 | 0 | -14 | 5 | 5 |
30 Jun 22 | 0 | -13 | 6 | 5 |
31 Mar 22 | 0 | -14 | 7 | 5 |
31 Dec 21 | 1 | -12 | 5 | 5 |
30 Sep 21 | 1 | -10 | 4 | 5 |
30 Jun 21 | 1 | -9 | 3 | 4 |
31 Mar 21 | 0 | -9 | 3 | 4 |
31 Dec 20 | 0 | -9 | 2 | 5 |
30 Sep 20 | 0 | -8 | 2 | 4 |
30 Jun 20 | 0 | -6 | 3 | 3 |
31 Mar 20 | 0 | -4 | 2 | 2 |
31 Dec 19 | 0 | -2 | 1 | 0 |
30 Sep 19 | 0 | -1 | 1 | 0 |
30 Jun 19 | 0 | -1 | 1 | 0 |
31 Mar 19 | 0 | -1 | 1 | 0 |
31 Dec 18 | 0 | -1 | 1 | 0 |
Quality Earnings: MGRM is currently unprofitable.
Growing Profit Margin: MGRM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MGRM is unprofitable, and losses have increased over the past 5 years at a rate of 31.9% per year.
Accelerating Growth: Unable to compare MGRM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MGRM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).
Return on Equity
High ROE: MGRM has a negative Return on Equity (-130.96%), as it is currently unprofitable.